BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28715816)

  • 1. Distinct Dynamics of Mitotic Transition in B-Cell Lymphoma and Reactive B-Cell Lymphoproliferations Determined by H3S10 Phosphohistone Immunolabeling.
    Méhes G; Hegyi K; Jobanputra R; Beke L; Vereb G; Bedekovics J
    Pathobiology; 2017; 84(5):243-250. PubMed ID: 28715816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas.
    Drakos E; Leventaki V; Atsaves V; Schlette EJ; Lin P; Vega F; Miranda RN; Claret FX; Medeiros LJ; Rassidakis GZ
    Hum Pathol; 2011 Aug; 42(8):1117-24. PubMed ID: 21315423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markers.
    Chiu KC; Fine M; Ikle D; Slovak ML; Arber DA
    Hum Pathol; 2003 Dec; 34(12):1259-64. PubMed ID: 14691911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
    Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
    Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas.
    Kunder CA; Roncador G; Advani RH; Gualco G; Bacchi CE; Sabile JM; Lossos IS; Nie K; Tibshirani RJ; Green MR; Alizadeh AA; Natkunam Y
    Am J Clin Pathol; 2017 Nov; 148(6):465-476. PubMed ID: 29140403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOX expression in cutaneous B-cell lymphomas.
    Schrader AM; Jansen PM; Willemze R
    Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma.
    Bedekovics J; Irsai G; Hegyi K; Beke L; Krenács L; Gergely L; Méhes G
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):579-585. PubMed ID: 27997502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation.
    Chimenti S; Cerroni L; Zenahlik P; Peris K; Kerl H
    J Cutan Pathol; 1996 Aug; 23(4):319-22. PubMed ID: 8864918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and clinical implications of reactive germinal centers in the bone marrow.
    Agbay RLMC; Medeiros LJ; Khoury JD; Salem A; Bueso-Ramos CE; Loghavi S
    Hum Pathol; 2017 Oct; 68():7-21. PubMed ID: 28428103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of glucocorticoid receptors in non-neoplastic lymphoid follicles and B cell type malignant lymphomas.
    Okazaki SI; Yamakawa M; Maeda K; Ohta N; Aoyagi M
    J Clin Pathol; 2006 Apr; 59(4):410-6. PubMed ID: 16461807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving precise counting of mitotic cells in mantle cell lymphoma using phosphohistone H3 (PHH3) antibody.
    Medani H; Elshiekh M; Naresh KN
    J Clin Pathol; 2021 Oct; 74(10):646-649. PubMed ID: 32873701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation.
    Hendzel MJ; Wei Y; Mancini MA; Van Hooser A; Ranalli T; Brinkley BR; Bazett-Jones DP; Allis CD
    Chromosoma; 1997 Nov; 106(6):348-60. PubMed ID: 9362543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma.
    Chang KC; Huang X; Medeiros LJ; Jones D
    J Pathol; 2003 Nov; 201(3):404-12. PubMed ID: 14595752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cells.
    Cha H; Dangi S; Machamer CE; Shapiro P
    Cell Signal; 2006 Jan; 18(1):93-104. PubMed ID: 15923109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
    Shi YF; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells. A single cell polymerase chain reaction analysis.
    Gellrich S; Rutz S; Golembowski S; Jacobs C; von Zimmermann M; Lorenz P; Audring H; Muche M; Sterry W; Jahn S
    J Invest Dermatol; 2001 Dec; 117(6):1512-20. PubMed ID: 11886516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phase.
    Rainey MD; Black EJ; Zachos G; Gillespie DA
    Oncogene; 2008 Feb; 27(7):896-906. PubMed ID: 17684483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional heterogeneity and pathogenic significance of interleukin-6 in B-cell lymphomas.
    Hsu SM; Xie SS; Waldron JA
    Am J Pathol; 1992 Oct; 141(4):915-23. PubMed ID: 1415484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin remodeling factor lymphoid-specific helicase links with Epstein-Barr virus associated the follicular germinal center B cell lymphomas.
    Ouyang C; Deng Z; Zhou J; Fu C; Liu S; Tao Y; Xiao D
    J Cancer Res Ther; 2019; 15(2):350-357. PubMed ID: 30964110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.